| induce multidrug resist… | 0.48 |
| prescribe information | 0.48 |
| decrease the clearance … | 0.42 |
| come as capsule | 0.34 |
| increase plasma flutica… | 0.34 |
| induce p-glycoprotein e… | 0.34 |
| inhibit saquinavir's me… | 0.34 |
| dosed with meal | 0.34 |
| induce cyp2c9 | 0.25 |
| demonstrate additive ef… | 0.25 |
| regimen | 0.48 |
| antiretroviral regimen | 0.34 |
| reduced serum cortisol … | 0.53 |
| a 174% | 0.42 |
| used in combination | 0.58 |
| administered with vincr… | 0.57 |
| administered at doses o… | 0.42 |
| co | 0.34 |
| withheld for prolonged … | 0.34 |
| approved for use | 0.25 |